These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13606730)

  • 41. Connective tissue reactions; a critical review. II. Hyaluronic acid, hyaluronidase, and the ground substance of the mesenchyme with particular reference to the collagen diseases.
    MIALE JB
    Ann Allergy; 1951; 9(4):545-52. PubMed ID: 14847443
    [No Abstract]   [Full Text] [Related]  

  • 42. [Histologic changes in diseases of rheumatologic significance].
    Raciti T; Vinci M; Giglio A
    Clin Ter; 1984 Jan; 108(1):43-7. PubMed ID: 6232041
    [No Abstract]   [Full Text] [Related]  

  • 43. [Rheumatic diseases with skin manifestations: connective tissue metabolism and immune mechanisms (basic research and clinical aspects). Vienna, 26-28 April 1984. Symposium].
    Z Rheumatol; 1984; 43 Suppl 1():1-55. PubMed ID: 6335330
    [No Abstract]   [Full Text] [Related]  

  • 44. [INCIDENCE OF THE LE PHENOMENON IN SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER COLLAGEN DISEASES BASED ON LONGITUDINAL OBSERVATIONS FOR SEVERAL YEARS].
    ZITNAN D; SVEC V; NIEPEL G
    Bratisl Lek Listy; 1964; 2():47-59. PubMed ID: 14167442
    [No Abstract]   [Full Text] [Related]  

  • 45. [Lesions of peripheral and cranial nerves in collagenoses].
    Kanareĭkin KF; Manvelov LS
    Klin Med (Mosk); 1983 Sep; 61(9):17-26. PubMed ID: 6139505
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment with hyaluronidase in dermatology].
    Wozniak KD; Braun W
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845
    [No Abstract]   [Full Text] [Related]  

  • 47. [USE OF THE DETERMINATION OF THE URINARY HYALURONIDASE ACTIVITY IN THE EVALUATION OF RHEUMATIC PROCESSES].
    TANIUKHINA EI
    Biull Eksp Biol Med; 1963 Oct; 55():22-5. PubMed ID: 14188218
    [No Abstract]   [Full Text] [Related]  

  • 48. [Loss of digital substance in rheumatic diseases. Apropos of 43 cases].
    Huaux JP; Esselinckx W; Meunier H; Dufour JP; Devogelaer JP; Nagant de Deuxchaisnes C
    Rev Rhum Mal Osteoartic; 1987; 54(7-9):549-53. PubMed ID: 3499655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dermal changes in rheumatic diseases].
    Kreysel HW; Kimmig J
    Internist (Berl); 1974 Jun; 15(6):304-11. PubMed ID: 4603062
    [No Abstract]   [Full Text] [Related]  

  • 50. [ALLERGY AND DISEASES OF THE CONNECTIVE TISSUE SYSTEM].
    ASBOE-HANSEN G
    Nord Med; 1965 Apr; 73():333-5. PubMed ID: 14265341
    [No Abstract]   [Full Text] [Related]  

  • 51. Systemic sclerosis: a collagen or microvascular disease?
    Jayson MI
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1855-7. PubMed ID: 6428575
    [No Abstract]   [Full Text] [Related]  

  • 52. Coexistence of systemic sclerosis, scleroderma-like syndromes and neoplastic diseases.
    Ciołkiewicz M; Domysławska I; Ciołkiewicz A; Klimiuk PA; Kuryliszyn-Moskal A
    Pol Arch Med Wewn; 2008 Mar; 118(3):119-26. PubMed ID: 18476458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antinucleolar antibodies. Their frequency and diagnostic association.
    Ritchie RF
    N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
    [No Abstract]   [Full Text] [Related]  

  • 54. [Rheumatism and hyaluronidase].
    VALDIGUIE P
    Gaz Med Fr; 1950 Apr; 57(8):409-11. PubMed ID: 15427797
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hyaluronidase and rheumatism].
    HEINLEIN H; RATHSCHECK R
    Arztl Wochensch; 1952 Apr; 7(17):385-7. PubMed ID: 12976226
    [No Abstract]   [Full Text] [Related]  

  • 56. Investigations into the effect of mechanical pressure on the water content of isolated skin.
    HVIDBERG E
    Acta Pharmacol Toxicol (Copenh); 1960; 16():245-9. PubMed ID: 14405686
    [No Abstract]   [Full Text] [Related]  

  • 57. [ROLE OF SOME INDICES IN THE EVALUATION OF THE SEVERITY AND ACTIVITY OF RHEUMATIC PROCESSES IN ACUTE AND POSTPAROXYSMAL STAGES OF RHEUMATISM].
    ABBASOVA AD
    Pediatriia; 1964 Jul; 43():57-60. PubMed ID: 14236338
    [No Abstract]   [Full Text] [Related]  

  • 58. [Evaluation of the dynamics of cutaneous changes under the influence of therapy of children with rheumatic diseases].
    LEWENFISZ-WOJNAROWSKA T; JABLONSKA S; ZAORSKA B
    Pathol Biol; 1960 Sep; 35():1061-74. PubMed ID: 24545822
    [No Abstract]   [Full Text] [Related]  

  • 59. [Differential diagnosis of arteritis].
    Emmrich R
    Z Gesamte Inn Med; 1974 Apr; 29(7):265-72. PubMed ID: 4153191
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antistreptolysin, antistrepto-hyaluronidase and C-reactive protein levels in rheumatic disease in children].
    GANCZARSKI A; MIKUCKI J
    Postepy Hig Med Dosw; 1959; 13():571-86. PubMed ID: 13826263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.